Literature DB >> 10645981

Antibodies to Borrelia burgdorferi in European populations.

J Gutiérrez1, M Guerrero, F Nuñez, M J Soto, G Piédrola, M C Maroto.   

Abstract

We compared the antibodies to B. burgdorferi in three different populations in order to evaluate the diagnostic reliability of Lyme borreliosis serologic analysis. The subjects included 25 patients with Lyme borreliosis (Group 1); 50 patients with diseases of unknown cause, B. burgdorferi ELISA-positive in serum and without B. burgdorferi infection (Group 2); and 1,251 individuals without Lyme borreliosis (Group 3). All samples were tested for B. burgdorferi B31 and B. afzelii antigens using ELISA. The positive results of the ELISA B. burgdorferi B31 assay were confirmed with Western blot for the same strain. In Group 3, 162 (12.9%) patients were ELISA positive for B. burgdorferi B31, while only 6 (0.6%) patients had IgG ELISA antibodies to B afzelii. Bands in WB were detected in 104 (8.4%) of the Group 3 subjects. The bands found to be most reliable for the identification of strain B. burgdorferi B31 by IgG WB were those representing the 93, 39, 34, and 23-kDa proteins. Our results show that serologic diagnosis of Lyme borreliosis is far from clearly established. To date, the only reliable criteria are clinical ones correlated with laboratory evidence. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10645981      PMCID: PMC6807830          DOI: 10.1002/(sici)1098-2825(2000)14:1<20::aid-jcla5>3.0.co;2-6

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  30 in total

1.  [Lyme disease in La Rioja].

Authors:  J A Oteo; V Martínez de Artola; J M Casas; A Estrada Peña
Journal:  Med Clin (Barc)       Date:  1991-04-20       Impact factor: 1.725

2.  Cross-reactive proteins of Borrelia burgdorferi.

Authors:  H R Bruckbauer; V Preac-Mursic; R Fuchs; B Wilske
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-03       Impact factor: 3.267

Review 3.  Antigenic and genetic structure of Borrelia burgdorferi.

Authors:  J Gutiérrez Fernández; M Rodríguez Fernández; F Nuñez Murillo; M C Maroto Vela
Journal:  Microbios       Date:  1997

4.  [Lyme borreliosis in children: double infection or atypical course].

Authors:  J Gutiérrez; F Núñez; N Utilla; C Maroto
Journal:  Med Clin (Barc)       Date:  1995-09-16       Impact factor: 1.725

5.  Immunoblot interpretation criteria for serodiagnosis of early Lyme disease.

Authors:  S M Engstrom; E Shoop; R C Johnson
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

6.  Analysis of Leptospira spp., Leptonema illini, and Rickettsia rickettsii for the 39-kilodalton antigen (P39) of Borrelia burgdorferi.

Authors:  T G Schwan; M E Schrumpf; K L Gage; R D Gilmore
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

7.  Comparison of western blot and microimmunofluorescence as tools for Lyme disease seroepidemiology.

Authors:  J P Arzouni; M Laveran; J Beytout; O Ramousse; D Raoult
Journal:  Eur J Epidemiol       Date:  1993-05       Impact factor: 8.082

8.  Comparison of immunoblotting and indirect enzyme-linked immunosorbent assay using different antigen preparations for diagnosing early Lyme disease.

Authors:  R L Grodzicki; A C Steere
Journal:  J Infect Dis       Date:  1988-04       Impact factor: 5.226

9.  Molecular mimicry and Lyme borreliosis: a shared antigenic determinant between Borrelia burgdorferi and human tissue.

Authors:  E Aberer; C Brunner; G Suchanek; H Klade; A Barbour; G Stanek; H Lassmann
Journal:  Ann Neurol       Date:  1989-12       Impact factor: 10.422

10.  Cross-reactivity between Borrelia burgdorferi flagellin and a human axonal 64,000 molecular weight protein.

Authors:  L H Sigal
Journal:  J Infect Dis       Date:  1993-06       Impact factor: 5.226

View more
  3 in total

1.  Borrelia burgdorferi sensu lato serology in the Netherlands: guidelines versus daily practice.

Authors:  J Coumou; J W R Hovius; A P van Dam
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-17       Impact factor: 3.267

2.  Screening of the prevalence of antibodies to Borrelia burgdorferi in Madrid province, Spain.

Authors:  Lourdes Lledó; María Isabel Gegúndez; José Vicente Saz; María Beltrán
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

3.  A seventeen-year epidemiological surveillance study of Borrelia burgdorferi infections in two provinces of northern Spain.

Authors:  Lourdes Lledó; María Isabel Gegúndez; Consuelo Giménez-Pardo; Rufino Álamo; Pedro Fernández-Soto; María Sofia Nuncio; José Vicente Saz
Journal:  Int J Environ Res Public Health       Date:  2014-01-30       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.